PCMM
EPZM

Private Capital Management (Minnesota)’s Epizyme, Inc EPZM Stock Holding History

Private Capital Management (Minnesota)’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$105K Buy
5,500
+500
+10% +$7.63K 0.12% 156
2017
Q2 		$76K Buy
5,000
+4,694
+1,534% +$71K 0.08% 168
2017
Q1 		$5K Buy
+306
New +$4.08K 0.01% 182

Other funds holding EPZM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Private Capital Management (Minnesota)'s EPZM Position: Q3 2017 in Review

Private Capital Management (Minnesota) increased its Epizyme, Inc (EPZM) stake by 10% in Q3 2017, buying an estimated $7.63K and bringing the position to 5,500 shares worth $105K. The position accounts for 0.12% of the portfolio, ranked #156.

Private Capital Management (Minnesota) first reported a position in EPZM in Q1 2017 and has held it in 3 quarters since. 104 funds tracked by Wall St. Rank hold EPZM as of Q3 2017.

  • Private Capital Management (Minnesota) held 5,500 shares of Epizyme, Inc worth $105K as of Q3 2017.
  • Private Capital Management (Minnesota) bought 500 Epizyme, Inc shares in Q3 2017, an estimated $7.63K.
  • Epizyme, Inc made up 0.12% of Private Capital Management (Minnesota)'s portfolio in Q3 2017, its #156 holding.
  • Private Capital Management (Minnesota) first reported a position in Epizyme, Inc in Q1 2017 and has held it in 3 quarters since.
  • 104 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2017.

Based on Private Capital Management (Minnesota)'s 13F filing for Q3 2017, filed 26 Oct 2017.